July 2023 – Page 2 – Policy & Medicine

Morris & Dickson’s Controlled Substance License Revoked

Will Insulin Pricing Change the Pharmaceutical Industry?

Senate Finance Committee Releases Framework for PBM Solutions

HIPAA Enforcement Discretion Ends as Part of COVID Public Health Emergency Ending

Bipartisan Senators Call for Action on Post-Fracture Osteoporosis Care

The Rise of Social Media Influencers in Pharmaceutical Industry Marketing

FDA Issues Draft Guidance on Decentralized Clinical Trials

OPDP Untitled Letters Are Back

Transparency, Aggregate Spend & HCP Engagement 2023

PatientView Releases 2022 Patient Group Survey on Pharmaceutical Industry